Microbix Biosystems Inc. (TSE:MBX) Senior Officer Sells C$30,295.15 in Stock

Microbix Biosystems Inc. (TSE:MBX) Senior Officer Mark Adrian Luscher sold 70,750 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of C$0.43, for a total transaction of C$30,295.15.

Mark Adrian Luscher also recently made the following trade(s):

• On Thursday, February 27th, Mark Adrian Luscher sold 6,000 shares of Microbix Biosystems stock. The shares were sold at an average price of C$0.45, for a total transaction of C$2,700.00.

Microbix Biosystems Trading Down 6.8 %

Shares of Microbix Biosystems stock opened at C$0.41 on Tuesday. The firm has a 50-day moving average of C$0.46 and a 200-day moving average of C$0.38. The stock has a market cap of C$54.00 million, a PE ratio of 15.62 and a beta of 0.34. Microbix Biosystems Inc. has a 52-week low of C$0.29 and a 52-week high of C$0.55. The company has a debt-to-equity ratio of 22.61, a quick ratio of 5.57 and a current ratio of 7.15.

Microbix Biosystems Company Profile

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.